The results of MTT assay showed that CT's inhibitory effect on ovarian cancer cell proliferation was obviously enhanced by the induction of SIRT3 shRNA‐1 when compared to controls (P < 0.05, Figure 2H). Here, SIRT3 is linked to ovarian cancer.